IR@PKUHSC  > 北京大学临床肿瘤学院
学科主题临床医学
A randomized open-label study comparing the docetaxel plus prednisone regimen versus mitoxantrone plus prednisone regimen for metastatic hormone refractory prostate cancer in Chinese population
Ye, D.1; Sun, Y. H.2; Wei, Q.3; Yao, X.4; Ye, Z. Q.5; Huang, Y. R.6; Zhang, W.7; Yang, Y.8; Tian, Y.9; Na, Y. Q.10
刊名EUROPEAN JOURNAL OF CANCER
2013-09-01
suppl.2页:S706-S706
收录类别SCI ; ISTP
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
语种英语
WOS记录号WOS:000326843604289
Citation statistics
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/67025
Collection北京大学临床肿瘤学院
作者单位1.Fudan Univ, Shanghai Canc Ctr, Shanghai 200433, Peoples R China
2.Peking Univ, Beijing Canc Hosp, Beijing 100871, Peoples R China
3.Peking Univ, Shougang Hosp, Beijing 100871, Peoples R China
4.Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China
5.Sichuan Univ, West China Hosp, West China Sch Med, Chengdu 610064, Peoples R China
6.Chinese PLA, Sch Med, Chinese PLA Gen Hosp, Beijing, Peoples R China
7.Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Wuhan 430074, Peoples R China
8.Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Shanghai 200030, Peoples R China
9.Nanjing Med Univ, Jiangsu Prov Hosp, Nanjing, Jiangsu, Peoples R China
10.Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China
Recommended Citation
GB/T 7714
Ye, D.,Sun, Y. H.,Wei, Q.,et al. A randomized open-label study comparing the docetaxel plus prednisone regimen versus mitoxantrone plus prednisone regimen for metastatic hormone refractory prostate cancer in Chinese population[J]. EUROPEAN JOURNAL OF CANCER,2013,suppl.2:S706-S706.
APA Ye, D..,Sun, Y. H..,Wei, Q..,Yao, X..,Ye, Z. Q..,...&Na, Y. Q..(2013).A randomized open-label study comparing the docetaxel plus prednisone regimen versus mitoxantrone plus prednisone regimen for metastatic hormone refractory prostate cancer in Chinese population.EUROPEAN JOURNAL OF CANCER,suppl.2,S706-S706.
MLA Ye, D.,et al."A randomized open-label study comparing the docetaxel plus prednisone regimen versus mitoxantrone plus prednisone regimen for metastatic hormone refractory prostate cancer in Chinese population".EUROPEAN JOURNAL OF CANCER suppl.2(2013):S706-S706.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Ye, D.]'s Articles
[Sun, Y. H.]'s Articles
[Wei, Q.]'s Articles
百度学术
百度学术Similar articles in
[Ye, D.]'s Articles
[Sun, Y. H.]'s Articles
[Wei, Q.]'s Articles
必应学术
必应学术Similar articles in
[Ye, D.]'s Articles
[Sun, Y. H.]'s Articles
[Wei, Q.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.